Rabiya Tuma. Show Affiliations »
Abstract
Entities: Disease
Mesh： See more » Adenoma/drug therapyAdenoma/prevention & controlAnimalsAnti-Inflammatory Agents, Non-Steroidal/administration & dosageAnti-Inflammatory Agents, Non-Steroidal/adverse effectsAnti-Inflammatory Agents, Non-Steroidal/therapeutic useAntineoplastic Combined Chemotherapy Protocols/administration & dosageAntineoplastic Combined Chemotherapy Protocols/adverse effectsAntineoplastic Combined Chemotherapy Protocols/therapeutic useCardiovascular System/drug effectsCelecoxibColonic Neoplasms/drug therapyColonic Neoplasms/prevention & controlDrug Administration ScheduleEflornithine/administration & dosageHumansNational Cancer Institute (U.S.)Neoplasm Recurrence, Local/prevention & controlPyrazoles/administration & dosageRandomized Controlled Trials as TopicSulfonamides/administration & dosageSulindac/administration & dosageUnited StatesUnited States Food and Drug Administration
Substances： See more » Anti-Inflammatory Agents, Non-SteroidalPyrazolesSulfonamidesSulindacCelecoxibEflornithine
Year: 2008 PMID： 18505958 DOI： 10.1093/jnci/djn187
Source DB: PubMed Journal: J Natl Cancer Inst ISSN： 0027-8874 Impact factor: 13.506